- PR Newswire•7 days agoLifshitz & Miller LLP Announces Investigation of Aetna Inc., GenVec, Inc., Ixia, McKesson Corporation, Meridian Bioscience, Inc., Novan, Inc., Regulus Therapeutics Incs., The Southern Company and The Western Union Company
NEW YORK, Feb. 17, 2017 /PRNewswire/ -- Aetna Inc. (AET) Lifshitz & Miller announces investigation on behalf of AET investors concerning AET's abandoned acquisition of Humana Inc. If you are an AET investor, ...
- PR Newswire•16 days ago
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of GenVec, Inc. ("GNVC" or the "Company") in connection with the proposed acquisition of the Company by Intrexon Corporation ("Intrexon"). Under the terms of the agreement, GNVC shareholders will receive 0.297 of a share of Intrexon for each share they own, representing consideration of $7.00 based on Intrexon's 5-day value weighted average price as of January 23, 2017. GNVC shareholders will also receive a right to contingent consideration equal to 50% of any milestones or royalty payments received within 36 months of closing of the transaction under GNVC's ongoing Research Collaboration and License Agreement with Novartis.
- Business Wire•18 days agoINVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of GenVec, Inc.
GNVC : Summary for GenVec, Inc. - Yahoo Finance
GenVec, Inc. (GNVC)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.31 x 1000|
|Day's Range||6.52 - 6.63|
|52 Week Range||0.27 - 10.44|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-2.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|